Abstract
Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.
| Original language | English |
|---|---|
| Pages (from-to) | 945-960 |
| Number of pages | 16 |
| Journal | European Heart Journal Cardiovascular Imaging |
| Volume | 18 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sep 1 2017 |
Fingerprint
Keywords
- Journal Article
Cite this
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients : A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH). / Perrone-Filardi, Pasquale; Coca, Antonio; Galderisi, Maurizio; Paolillo, Stefania; Alpendurada, Francisco; de Simone, Giovanni; Donal, Erwan; Kahan, Thomas; Mancia, Giuseppe; Redon, Josep; Schmieder, Roland; Williams, Bryan; Agabiti-Rosei, Enrico.
In: European Heart Journal Cardiovascular Imaging, Vol. 18, No. 9, 01.09.2017, p. 945-960.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients
T2 - A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)
AU - Perrone-Filardi, Pasquale
AU - Coca, Antonio
AU - Galderisi, Maurizio
AU - Paolillo, Stefania
AU - Alpendurada, Francisco
AU - de Simone, Giovanni
AU - Donal, Erwan
AU - Kahan, Thomas
AU - Mancia, Giuseppe
AU - Redon, Josep
AU - Schmieder, Roland
AU - Williams, Bryan
AU - Agabiti-Rosei, Enrico
N1 - © The Authors, 2017. This article has been co-published in European Heart Journal - Cardiovascular Imaging and Journal of Hypertension The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.
AB - Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.
KW - Journal Article
U2 - 10.1093/ehjci/jex094
DO - 10.1093/ehjci/jex094
M3 - Article
VL - 18
SP - 945
EP - 960
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
SN - 2047-2404
IS - 9
ER -